Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4028874016 | Tafasitamab-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4028875015 | Product containing tafasitamab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tafasitamab-containing product | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Tafasitamab-containing product | Is a | Antineoplastic agent | false | Inferred relationship | Some | ||
| Tafasitamab-containing product | Is a | Product containing monoclonal antibody (product) | false | Inferred relationship | Some | ||
| Tafasitamab-containing product | Has active ingredient | Tafasitamab (substance) | true | Inferred relationship | Some | 1 | |
| Tafasitamab-containing product | Is a | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only tafasitamab (medicinal product) | Is a | True | Tafasitamab-containing product | Inferred relationship | Some | |
| Product containing tafasitamab in parenteral dose form (medicinal product form) | Is a | True | Tafasitamab-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR